$96.581.35%1.29

Colgate Palmolive Co (CL)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$95.29

Offen:

$95.91

24-Stunden-Volumen:

1,906,579

Relatives Volumen:

0.39

Marktkapitalisierung:

$76.77B

Einnahmen:

$20.80B

Nettoeinkommen (Verlust:

$2.22B

KGV:

37.47

EPS:

$2.58

Netto-Cashflow:

$3.77B

1W Leistung:

+3.74%

1M Leistung:

+14.62%

6M Leistung:

+10.68%

1Y Leistung:

+25.35%

1-Tages-Spanne:

$95.89$97.25

1-Wochen-Bereich:

$90.47$98.38

52-Wochen-Spanne:

$74.55$99.33

Colgate Palmolive Co Aktie (CL) Unternehmensprofil

Firmenname

Colgate Palmolive Co

Sektor

Consumer Defensive

Branche

Household & Personal Products

Telefon

(212) 310-2000

Adresse

300 PARK AVE, NEW YORK, NY, USA

Mitarbeiter

33,600

@colgate

Nächster Verdiensttermin

null

Neueste SEC-Einreichungen

SEC

CL-Diskussionen auf X

CL vs. PG, UL, EL, KVUE vergleichen

Aktien	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CL Colgate Palmolive Co	$76.77B	$21.28B	$2.05B	$3.77B	$2.58
PG Procter Gamble Co	$378.11B	$87.92B	$16.03B	$15.03B	$6.84
UL Unilever Plc Adr	$142.92B	$56.67B	$6.96B	$7.39B	$3.13
EL Estee Lauder Cos Inc	$38.80B	$15.05B	$182.00M	$1.29B	-$0.6966
KVUE Kenvue Inc	$37.11B	$15.53B	$1.69B	$1.82B	$0.8433

Colgate Palmolive Co Aktie (CL) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-06-12	Eingeleitet	Bernstein	Mkt Perform
2026-04-21	Hochstufung	Rothschild & Co Redburn	Neutral → Buy
2026-03-31	Herabstufung	TD Cowen	Buy → Hold
2026-03-30	Hochstufung	Deutsche Bank	Hold → Buy
2026-01-13	Hochstufung	Wells Fargo	Underweight → Equal Weight
2026-01-07	Hochstufung	Piper Sandler	Neutral → Overweight
2025-12-11	Herabstufung	Argus	Buy → Hold
2025-12-09	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2025-10-03	Resumed	Piper Sandler	Neutral
2024-10-28	Herabstufung	Stifel	Buy → Hold
2024-09-24	Eingeleitet	Piper Sandler	Overweight
2024-09-16	Herabstufung	Wells Fargo	Equal Weight → Underweight
2024-09-09	Herabstufung	Deutsche Bank	Buy → Hold
2024-07-26	Herabstufung	HSBC Securities	Buy → Hold
2024-07-24	Herabstufung	Jefferies	Buy → Hold
2024-07-23	Eingeleitet	TD Cowen	Buy
2024-06-24	Eingeleitet	Exane BNP Paribas	Outperform
2024-03-01	Resumed	Goldman	Buy
2024-01-29	Hochstufung	Raymond James	Mkt Perform → Outperform
2023-12-15	Hochstufung	BofA Securities	Neutral → Buy
2023-11-13	Eingeleitet	Jefferies	Buy
2023-10-16	Hochstufung	Stifel	Hold → Buy
2023-09-22	Eingeleitet	HSBC Securities	Buy
2023-02-17	Eingeleitet	Citigroup	Buy
2023-01-30	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-11-22	Eingeleitet	Wolfe Research	Peer Perform
2022-10-13	Hochstufung	JP Morgan	Neutral → Overweight
2022-08-01	Hochstufung	Wells Fargo	Underweight → Equal Weight
2022-05-03	Herabstufung	Atlantic Equities	Overweight → Neutral
2022-04-08	Eingeleitet	Raymond James	Mkt Perform
2022-02-02	Hochstufung	Bernstein	Underperform → Mkt Perform
2022-01-31	Bestätigt	Citigroup	Neutral
2022-01-31	Bestätigt	Credit Suisse	Outperform
2022-01-31	Bestätigt	Deutsche Bank	Buy
2022-01-31	Bestätigt	Morgan Stanley	Equal-Weight
2022-01-31	Bestätigt	Wells Fargo	Underweight
2021-12-16	Eingeleitet	Redburn	Neutral
2021-10-05	Resumed	BofA Securities	Neutral
2021-09-20	Hochstufung	Deutsche Bank	Hold → Buy
2021-06-24	Eingeleitet	UBS	Buy
2021-06-09	Hochstufung	Credit Suisse	Neutral → Outperform
2021-02-01	Hochstufung	Credit Suisse	Underperform → Neutral
2021-01-28	Herabstufung	Stifel	Buy → Hold
2021-01-26	Hochstufung	Berenberg	Sell → Hold
2021-01-20	Eingeleitet	Bernstein	Underperform
2021-01-04	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2020-12-08	Eingeleitet	Wells Fargo	Underweight
2020-07-22	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-03-27	Hochstufung	Stifel	Hold → Buy
2020-03-27	Hochstufung	SunTrust	Hold → Buy
2020-03-23	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-03-20	Hochstufung	BofA/Merrill	Neutral → Buy
2020-02-03	Hochstufung	Atlantic Equities	Neutral → Overweight
2020-02-03	Hochstufung	RBC Capital Mkts	Sector Perform → Outperform
2019-12-19	Herabstufung	BofA/Merrill	Buy → Neutral
2019-10-16	Eingeleitet	Berenberg	Sell
2019-04-29	Hochstufung	JP Morgan	Underweight → Neutral
2019-03-07	Eingeleitet	Credit Suisse	Underperform
2019-02-11	Hochstufung	Exane BNP Paribas	Underperform → Neutral
2019-01-11	Eingeleitet	Evercore ISI	Outperform
2019-01-09	Hochstufung	Goldman	Neutral → Buy
2018-10-29	Herabstufung	JP Morgan	Neutral → Underweight
2018-10-26	Herabstufung	SunTrust	Buy → Hold
2018-07-30	Herabstufung	Macquarie	Outperform → Neutral
2018-05-25	Hochstufung	Argus	Hold → Buy
2018-04-30	Herabstufung	Morgan Stanley	Overweight → Equal-Weight

Finanzdaten der Colgate Palmolive Co-Aktie (CL)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	20,382.00	20,101.00	19,457.00	17,967.00	17,421.00
Cost of revenue USD (M)	8,131.00	7,940.00	8,131.00	7,719.00	7,046.00
Gross profit USD (M)	12,251.00	12,161.00	11,326.00	10,248.00	10,375.00
Research and development USD (M)	366.00	355.00	343.00	320.00	307.00
Operating expenses USD (M)	-	-	7,342.00	7,355.00	7,043.00
Operating income USD (M)	3,306.00	4,268.00	3,984.00	2,893.00	3,332.00
Income before tax USD (M)	3,059.00	3,956.00	3,392.00	2,660.00	3,087.00
Income tax expense USD (M)	798.00	907.00	937.00	693.00	749.00
Net income USD (M)	2,261.00	3,049.00	2,455.00	1,967.00	2,338.00
Basic EPS USD/shares	2.64	3.53	2.78	2.13	2.56
Diluted EPS USD/shares	2.63	3.51	2.77	2.13	2.55
Basic weighted shares shares (M)	808.70	819.10	827.40	836.40	845.00
Diluted weighted shares shares (M)	811.10	823.20	829.20	838.80	848.30
Selling, general and administrative USD (M)	7,903.00	7,729.00	7,151.00	6,565.00	6,407.00

Colgate Palmolive Co-Aktie (CL) Insiderhandel

Tsourapas PanagiotisAug 24 '26
Officer
Transaktion
Proposed Sale
Kosten
$92.05
#Aktien
10,000
Wert ($)
920,477
#Aktien Gesamt
0
CAHILL JOHN TAug 06 '26
Director
Transaktion
Option Exercise
Kosten
$71.56
#Aktien
4,170
Wert ($)
298,405
#Aktien Gesamt
32,543
CAHILL JOHN TAug 06 '26
Director
Transaktion
Sale
Kosten
$93.37
#Aktien
4,170
Wert ($)
389,358
#Aktien Gesamt
28,373
CAHILL JOHN TAug 06 '26
Director
Transaktion
Proposed Sale
Kosten
$93.37
#Aktien
4,170
Wert ($)
389,358
#Aktien Gesamt
0
Wallace Noel R.Aug 05 '26
Chairman, President & CEO
Transaktion
Sale
Kosten
$92.52
#Aktien
161,021
Wert ($)
14,897,904
#Aktien Gesamt
362,231
Wallace Noel R.Aug 05 '26
Officer
Transaktion
Proposed Sale
Kosten
$92.52
#Aktien
161,021
Wert ($)
14,897,912
#Aktien Gesamt
0
Wallace Noel R.Aug 04 '26
Officer
Transaktion
Proposed Sale
Kosten
$91.92
#Aktien
161,021
Wert ($)
14,800,720
#Aktien Gesamt
0
Wallace Noel R.Aug 04 '26
Chairman, President & CEO
Transaktion
Sale
Kosten
$91.92
#Aktien
161,021
Wert ($)
14,800,712
#Aktien Gesamt
362,231
CAHILLANE STEVEN AAug 04 '26
Officer
Transaktion
Proposed Sale
Kosten
$90.57
#Aktien
1,762
Wert ($)
159,584
#Aktien Gesamt
0
Wallace Noel R.Aug 04 '26
Chairman, President & CEO
Transaktion
Option Exercise
Kosten
$72.29
#Aktien
161,021
Wert ($)
11,640,208
#Aktien Gesamt
523,252

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Tsourapas Panagiotis	Officer	Aug 24 '26	Proposed Sale	$92.05	10,000	920,477	0
CAHILL JOHN T	Director	Aug 06 '26	Option Exercise	$71.56	4,170	298,405	32,543
CAHILL JOHN T	Director	Aug 06 '26	Sale	$93.37	4,170	389,358	28,373
CAHILL JOHN T	Director	Aug 06 '26	Proposed Sale	$93.37	4,170	389,358	0
Wallace Noel R.	Chairman, President & CEO	Aug 05 '26	Sale	$92.52	161,021	14,897,904	362,231
Wallace Noel R.	Officer	Aug 05 '26	Proposed Sale	$92.52	161,021	14,897,912	0
Wallace Noel R.	Officer	Aug 04 '26	Proposed Sale	$91.92	161,021	14,800,720	0
Wallace Noel R.	Chairman, President & CEO	Aug 04 '26	Sale	$91.92	161,021	14,800,712	362,231
CAHILLANE STEVEN A	Officer	Aug 04 '26	Proposed Sale	$90.57	1,762	159,584	0
Wallace Noel R.	Chairman, President & CEO	Aug 04 '26	Option Exercise	$72.29	161,021	11,640,208	523,252

Colgate Palmolive Co Aktie (CL) Neueste Nachrichten

Nov 01, 2026

Colgate-Palmolive vs. Lululemon Athletica: Which Consumer Goods Stock Is a Better Buy in 2026? - The Motley Fool

Nov 01, 2026

Oct 30, 2026

Dividend stocks alert: Record date Mon 2 Nov: Colgate Palmolive vs Pitti Engineering vs Route Mobile vs Tanla Platforms - TradingView

Oct 30, 2026

Colgate-Palmolive lifts earnings outlook as North America weakness persists - finchannel

Oct 30, 2026

Hill’s Pet Nutrition sales up 5.6% in Q3 2026, beats Colgate-Palmolive - PetfoodIndustry

Oct 30, 2026

Colgate-Palmolive Sales Rise Despite U.S. Consumer Challenges - WSJ

Oct 30, 2026

Colgate-Palmolive Q3 Sales Rise 4.6% to $5.37 Billion - grafa.com

Oct 30, 2026

Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains - Zacks Investment Research

Oct 30, 2026

Colgate Q3 Earnings Beat Estimates on Organic Sales & Pricing Gains - Yahoo Finance

Oct 30, 2026

Colgate-Palmolive Lifts Full-Year Earnings Growth Outlook Following Third-Quarter Beat - Yahoo Finance

Oct 30, 2026

Colgate-Palmolive Beats Q3 Estimates, Raises Profit Outlook Despite Weak US Demand, Rising Costs - Benzinga

Oct 30, 2026

Clorox's Q1 Earnings Coming Up: Key Insights for Investors - Zacks Investment Research

Oct 30, 2026

Colgate-Palmolive Company reports results for the quarter ended September 30 - Earnings Summary - TradingView

Oct 30, 2026

Colgate-Palmolive Releases Q3 2026 Financial Results - AlphaStreet

Oct 30, 2026

Colgate-Palmolive (NYSE:CL) posts better-than-expected sales in Q3 2026, stock soars - FinancialContent

Oct 30, 2026

Colgate-Palmolive Co Reports Q3 2026 Earnings: Revenue of $5,369 - GuruFocus

Oct 30, 2026

Colgate-Palmolive (CL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Oct 30, 2026

Colgate-Palmolive Company Q3 2026 Earnings Call Is Live - TradingView

Oct 30, 2026

Colgate-Palmolive Q3 2026 earnings beat estimates, outlook raised - Quartz

Oct 30, 2026

Colgate-Palmolive gains after Q3 sales beat, higher earnings forecast (CL:NYSE) - Seeking Alpha

Oct 30, 2026

Colgate-Palmolive (CL) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance

Oct 30, 2026

Colgate-Palmolive (CL) Surpasses Q3 Earnings and Revenue Estimates - Zacks Investment Research

Oct 30, 2026

Colgate-Palmolive's Q3 net sales up 4.6% to $5.4B - Breakingthenews.net

Oct 30, 2026

Colgate-Palmolive: Q3 Earnings Snapshot - 10TV

Oct 30, 2026

Oct 29, 2026

Kenvue's Q3 Earnings on the Horizon: Key Insights for Investors - Zacks Investment Research

Oct 29, 2026

Oct 27, 2026

BJ vs. CL: Which Stock Is the Better Value Option? - Zacks Investment Research

Oct 27, 2026

Here's Why Colgate-Palmolive (CL) is a Strong Growth Stock - Zacks Investment Research

Oct 27, 2026

Oil Prices Drop as Diplomatic Efforts Increase - GuruFocus

Oct 27, 2026

Oct 26, 2026

Crude Oil Market Reacts to Middle East Diplomacy; Colgate-Palmolive (CL) Dividend Stability in Focus - GuruFocus

Oct 26, 2026

Colgate-Palmolive (CL) Q3 2026 Preview: EPS Est. $0.93, Reports October 30 - AlphaStreet

Oct 26, 2026

Colgate to Report Q3 Earnings: What Should Investors Expect? - Zacks Investment Research

Oct 26, 2026

Colgate to Report Q3 Earnings: What Should Investors Expect? - TradingView

Oct 26, 2026

Is This Safe-Haven Stock Overvalued? The Hidden Risk Facing Colgate-Palmolive on Oct. 30 - 24/7 Wall St.

Oct 26, 2026

Newell Gears Up to Report Q3 Earnings: What's in the Offing? - Zacks Investment Research

Oct 26, 2026

Is This Safe-Haven Stock Overvalued? The Hidden Risk Facing Colgate-Palmolive on Oct. 30 - Yahoo Finance

Oct 26, 2026

Is This Safe-Haven Stock Overvalued? The Hidden Risk Facing Colgate-Palmolive on Oct. 30 - AOL.com

Oct 26, 2026

PG vs. CL: Which Household Giant Deserves Your Retirement Dollars? - 24/7 Wall St.

Oct 26, 2026

Colgate-Palmolive India: Nomura maintains 'Buy', cuts target price to Rs 2,175 - TradingView

Oct 26, 2026

Oct 24, 2026

11,301 Shares of Colgate-Palmolive Company $CL Purchased by NBT Bank N.A. - MarketBeat

Oct 24, 2026

Oct 23, 2026

Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027? - The Motley Fool

Oct 23, 2026

Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027? - The Motley Fool

Oct 23, 2026

Colgate-Palmolive Company (CL) Stock forecasts - Yahoo Finance UK

Oct 23, 2026

Colgate-Palmolive (NYSE:CL) Stock Sees Unusually High Put Option Buying - MarketBeat

Oct 23, 2026

Colgate-Palmolive options signal 2.9% move on Oct. 30 earnings - Investing.com

Oct 23, 2026

Colgate-Palmolive options signal 2.9% move on Oct. 30 earnings By Investing.com - Investing.com Canada

Oct 23, 2026

Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 23, 2026

Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Zacks Investment Research

Oct 23, 2026

Colgate-Palmolive Company Estimates – NYSE:CL - TradingView

Oct 23, 2026

Precedent Wealth Partners LLC Acquires New Holdings in Colgate-Palmolive Company $CL - MarketBeat

Oct 23, 2026

Crossmark Global Holdings Inc. Sells 14,889 Shares of Colgate-Palmolive Company $CL - MarketBeat

Oct 23, 2026

Colgate-Palmolive India appoints Akash Parekh as EVP – Marketing; Gunjit Jain resigns - Indian Television Dot Com

Oct 23, 2026

Ähnlich wie CL